ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy?
ESMO Colloquium
Calendar Export
Are immune checkpoints (ICPs) better as single agent, doublet ICPs or combined with chemo +/- anti-angiogenics?
Lecture Time
12:30 - 12:50
Speakers
S. Peters
(Lausanne, Switzerland)
Session Name
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy?
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
S. Peters
(Lausanne, Switzerland)